Oragenics (NYSE American: OGEN) announced the submission of its Phase II clinical trial protocol to New Zealand's Health and Disability Ethics Commit ...

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for ...

Will Pucovski, once touted as the next big thing in Australian cricket, has announced his retirement at just 27 years old.

People living with concussion in regional Western Australian communities will now have access to a groundbreaking national study which will help to ...

Two studies by scientists at Hospital for Special Surgery (HSS) offer possible insights into treating mild traumatic brain injury (mTBI), including a potential blood biomarker for injury assessment ...

TBI-Predict meets significant recruitment milestone that will help advance understanding of concussion and the likelihood of ...

With the rugby season in full swing across South Africa, understanding the risks of head injuries is crucial. This article explores the importance of early detection and advanced imaging techniques in ...

With the rugby season kicking off in South African schools, understanding the risks of head injuries is crucial.

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly ...

University of Montreal-led research has found that children who sustain concussion may need three months or longer to be ...

March is Brain Injury Month and while it has passed and spring is here, bringing attention and support to an issue often overlooked in the Black community continues year-round. The Brain Injury ...

Reduced blood flow and altered white matter in the brain following sports-related concussions persist up to a year after ...